Volumen | 0 |
|
|||||
News | - |
Finanzwerte MBRX
Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
---|---|---|---|---|---|---|
132,98M | 33,41M | - | 0 | -29,77M | -0,89 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Moleculin Biotech
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
18.6.2024 | 23:00 | Edgar (US Regulatory) | Form 8-K - Current report |
14.6.2024 | 14:00 | Edgar (US Regulatory) | Form 8-K - Current report |
14.6.2024 | 14:00 | PR Newswire (US) | Moleculin Announces Additional Positive Preliminary Interim.. |
12.6.2024 | 15:00 | PR Newswire (US) | Moleculin to Present at the Virtual Investor Pitch.. |
07.6.2024 | 23:05 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
05.6.2024 | 14:55 | PR Newswire (US) | Moleculin to Participate in the Virtual Investor Lunch Break.. |
16.5.2024 | 14:32 | Edgar (US Regulatory) | Form 8-K - Current report |
16.5.2024 | 14:32 | PR Newswire (US) | Moleculin Abstract Accepted for Poster Presentation at the.. |
15.5.2024 | 14:38 | Edgar (US Regulatory) | Form 8-K - Current report |
15.5.2024 | 14:38 | PR Newswire (US) | Moleculin Announces Commencement of NIH-Funded Phase 2.. |
14.5.2024 | 22:16 | Edgar (US Regulatory) | Form 8-K - Current report |
13.5.2024 | 16:53 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
Forum Moleculin Biotech
Keine Diskussionen Gefunden.Neuen Thread Erstellen
MBRX Historisch
Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
---|---|---|---|---|---|---|---|
1 Woche | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
1 Monat | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
3 Monate | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
6 Monate | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
1 Jahr | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
3 Jahre | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
5 Jahre | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |